EXEL CIK: 939767

Exelixis Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.38
FY22:
1.55
FY23:
1.76
FY24:
2.09
FY25:
2.24
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.29
FY22:
0.20
FY23:
0.17
FY24:
0.60
FY25:
0.87
(positive)
billions USD
FY21:
0.30
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
billions USD
FY21:
0.29
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.23
FY22:
0.18
FY23:
0.21
FY24:
0.52
FY25:
0.78

All amounts in billions USD Data sources:SEC EDGARTwelve Data